Braskem (BAK) Capital Expenditures (2009 - 2021)

Braskem (BAK) has reported Capital Expenditures for 12 consecutive years, with $247.1 million the latest figure, recorded in Q4 2021.

• Quarterly Capital Expenditures rose 60.85% year-over-year to $247.1 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $1.5 billion (up 58.52% YoY) and the FY2025 annual result came in at $573.5 million, down 11.38% from the prior year.
• Capital Expenditures climbed to $247.1 million in Q4 2021 per BAK's latest filing, from $153.6 million in the prior quarter.
• Over the last five years, Capital Expenditures for BAK reached as high as $1.6 billion in Q4 2018 and fell as low as -$479.1 million in Q3 2017.
• A 4-year average of $177.4 million and a median of -$105.8 million in 2017 frame the typical range for Capital Expenditures.
• Annual changes were most pronounced in 2018 — Capital Expenditures tumbled 43.51% — and 2021, when it jumped 60.85%.
• Year by year, Capital Expenditures stood at $1.5 billion in 2017, then gained by 7.22% to $1.6 billion in 2018, then slumped by 90.35% to $153.6 million in 2020, then soared by 60.85% to $247.1 million in 2021.
• According to Business Quant data, Capital Expenditures over the past three periods registered $247.1 million, $153.6 million, and $1.6 billion for Q4 2021, Q4 2020, and Q4 2018 respectively.